Efficacy and Safety of Ribavirin with Sofosbuvir Plus Ledipasvir in Patients with Genotype 1 Hepatitis C: A Meta-Analysis

被引：0
|
作者：
Qiu-Feng He
Qiong-Fang Zhang
Da-Zhi Zhang
机构：
[1] Chongqing Medical University,Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital
来源：
Digestive Diseases and Sciences | 2016年 / 61卷
关键词：
Genotype 1 hepatitis C; Sofosbuvir; Ledipasvir; Ribavirin; Efficacy; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3108 / 3117
页数：9
相关论文
共 50 条
  • [21] Safety and efficacy of ledipasvir/sofosbuvir with or without ribavirin in hepatitis C genotype 1 patients including those with decompensated cirrhosis who failed prior treatment with simeprevir/sofosbuvir
    Modi, A. A.
    Nazario, H. E.
    Gonzales, G. R.
    Gonzalez, S. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (10) : 1409 - 1415
  • [22] Efficacy and safety of sofosbuvir and ledipasvir in Japanese patients aged 75 years or over with hepatitis C genotype 1
    Yoshinori Ozono
    Kenji Nagata
    Satoru Hasuike
    Hisayoshi Iwakiri
    Kenichi Nakamura
    Mai Tsuchimochi
    Yuri Yamada
    Yuka Takaishi
    Mitsue Sueta
    Tadashi Miike
    Yoshihiro Tahara
    Shojiro Yamamoto
    Kotaro Shide
    Tomonori Hidaka
    Yoko Kubuki
    Kazunori Kusumoto
    Toshimasa Ochiai
    Junya Kato
    Naoto Komada
    Shuichi Hirono
    Kazuo Kuroki
    Masafumi Shigehira
    Kazuya Shimoda
    World Journal of Hepatology, 2017, (36) : 1340 - 1345
  • [23] Safety and efficacy of sofosbuvir plus velpatasvir with or without ribavirin for chronic hepatitis C virus infection: A systematic review and meta-analysis
    Ahmed, Hussien
    Abushouk, Abdelrahman I.
    Attia, Attia
    Gadelkarim, Mohamed
    Gabr, Mohamed
    Negida, Ahmed
    Abdel-Daim, Mohamed M.
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2018, 11 (02) : 156 - 164
  • [24] Compare the Efficacy of Sofosbuvir Plus Ribavirin Verus Sofosbuvir Plus Daclatasvir in Patients with Chronic C Hepatitis Genotype 2 Infection
    Chang, Kuo-Chin
    Hu, Tsung-Hui
    Chen, Chien Hung
    Wang, Jing-Houng
    HEPATOLOGY, 2018, 68 : 586A - 586A
  • [25] Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis
    Rezaee-Zavareh, Mohammad Saeid
    Hesamizadeh, Khashayar
    Behnava, Bita
    Alavian, Seyed Moayed
    Gholami-Fesharaki, Mohammad
    Sharafi, Heidar
    ANNALS OF HEPATOLOGY, 2017, 16 (02) : 188 - 197
  • [26] Efficacy and safety of ledipasvir/sofosbuvir for genotype 1b chronic hepatitis C patients with moderate renal impairment
    Tomomi Okubo
    Masanori Atsukawa
    Akihito Tsubota
    Hidenori Toyoda
    Noritomo Shimada
    Hiroshi Abe
    Keizo Kato
    Korenobu Hayama
    Taeang Arai
    Ai Nakagawa-Iwashita
    Norio Itokawa
    Chisa Kondo
    Chiaki Kawamoto
    Etsuko Iio
    Yasuhito Tanaka
    Takashi Kumada
    Katsuhiko Iwakiri
    Hepatology International, 2018, 12 : 133 - 142
  • [27] Safety and efficacy of sofosbuvir and ribavirin for genotype 2 hepatitis C Japanese patients with renal dysfunction
    Sho, Takuya
    Suda, Goki
    Nagasaka, Atsushi
    Yamamoto, Yoshiya
    Furuya, Ken
    Kumagai, Kenichi
    Uebayashi, Minoru
    Terashita, Katsumi
    Kobayashi, Tomoe
    Tsunematsu, Izumi
    Onodera, Manabu
    Meguro, Takashi
    Kimura, Megumi
    Ito, Jun
    Umemura, Machiko
    Izumi, Takaaki
    Kawagishi, Naoki
    Ohara, Masatsugu
    Ono, Yuji
    Nakai, Masato
    Natsuizaka, Mitsuteru
    Morikawa, Kenichi
    Ogawa, Koji
    Sakamoto, Naoya
    HEPATOLOGY RESEARCH, 2018, 48 (07) : 529 - 538
  • [28] Efficacy and safety of ledipasvir/sofosbuvir for genotype 1b chronic hepatitis C patients with moderate renal impairment
    Okubo, Tomomi
    Atsukawa, Masanori
    Tsubota, Akihito
    Toyoda, Hidenori
    Shimada, Noritomo
    Abe, Hiroshi
    Kato, Keizo
    Hayama, Korenobu
    Arai, Taeang
    Nakagawa-Iwashita, Ai
    Itokawa, Norio
    Kondo, Chisa
    Kawamoto, Chiaki
    Iio, Etsuko
    Tanaka, Yasuhito
    Kumada, Takashi
    Iwakiri, Katsuhiko
    HEPATOLOGY INTERNATIONAL, 2018, 12 (02) : 133 - 142
  • [29] SIMEPREVIR AND SOFOSBUVIR WITH OR WITHOUT RIBAVIRIN IN GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS: EFFICACY AND SAFETY IN REAL LIFE
    Ramos, H.
    Gomez, J.
    Linares, P.
    Martin, I.
    Almohalla, C.
    Jorquera, F.
    Garcia, I.
    Vasquez, M.
    Conde, P.
    Badia, E.
    Alvarez, B.
    Karpman, G.
    Lorenzo, S.
    Gozalo, V.
    Joao, D.
    de Benito, M.
    Ruiz, L.
    Jimenez, F.
    Saez-Rouela, F.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S765 - S766
  • [30] Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and Cirrhosis
    Lim, Joseph K.
    Liapakis, Ann Marie
    Shiffman, Mitchell L.
    Lok, Anna S.
    Zeuzem, Stefan
    Terrault, Norah A.
    Park, James S.
    Landis, Charles S.
    Hassan, Mohamed
    Gallant, Joel
    Kuo, Alexander
    Pockros, Paul J.
    Vainorius, Monika
    Akushevich, Lucy
    Michael, Larry
    Fried, Michael W.
    Nelson, David R.
    Ben-Ari, Ziv
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (11) : 1811 - +
12345